Anti-parietal cell autoimmunity is associated with an accelerated decline of lung function in IPF patients-Reference-Cited by-同舟云学术

Anti-parietal cell autoimmunity is associated with an accelerated decline of lung function in IPF patients

Published:2018-02 Issue: Volume:135 Page:15-21
ISSN:0954-6111
Container-title:Respiratory Medicine
language:en
Short-container-title:Respiratory Medicine

Author:

Beltramo Guillaume^ORCID,Thabut Gabriel,Peron Nicolas,Nicaise Pascale,Cazes Aurélie,Debray Marie-Pierre,Joannes Audrey^ORCID,Castier Yves,Mailleux Arnaud A.,Frija Justine,Pradère Pauline,Justet Aurélien,Borie Raphaël,Dombret Marie-Christine,Taille Camille,Aubier Michel,Crestani Bruno^ORCID

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference48 articles.

1. New cellular and molecular mechanisms of lung injury and fibrosis in idiopathic pulmonary fibrosis;Fernandez;Lancet,2012

2. Idiopathic pulmonary fibrosis: from epithelial injury to biomarkers–insights from the bench side;Borensztajn;Respiration,2013

3. High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis;Raghu;Eur. Respir. J.,2006

4. Idiopathic pulmonary fibrosis: novel concepts of proton pump inhibitors as antifibrotic drugs;Ghebre;Am. J. Respir. Crit. Care Med.,2016

5. Laparoscopic anti-reflux surgery for idiopathic pulmonary fibrosis at a single centre;Raghu;Eur. Respir. J.,2016

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-mutated citrullinated vimentin antibodies are increased in IPF patients;Respiratory Medicine and Research;2024-06

2. Anti-parietal cell antibodies as a potential biomarker for interstitial lung disease associated with primary Sjögren's syndrome;Medicina Clínica;2024-01

3. Anti-parietal cell antibodies as a potential biomarker for interstitial lung disease associated with primary Sjögren's syndrome;Medicina Clínica (English Edition);2024-01

4. Mass spectrometry-based autoimmune profiling reveals predictive autoantigens in idiopathic pulmonary fibrosis;iScience;2023-11

5. No increased prevalence of autoantibodies neutralizing type I IFNs in idiopathic pulmonary fibrosis patients;Respiratory Research;2023-03-20